Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient

[1]  M. Bulanda,et al.  In Vitro Activities of a Wide Panel of Antifungal Drugs against Various Scopulariopsis and Microascus Species , 2015, Antimicrobial Agents and Chemotherapy.

[2]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  M. Rodríguez-Iglesias,et al.  [Antifungal susceptibility of clinical isolates of Scopulariopsis species]. , 2014, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[4]  P. García-Martos,et al.  Sensibilidad a antifúngicos de especies de Scopulariopsis de origen clínico , 2014 .

[5]  P. Iwen,et al.  Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. , 2012, Medical mycology.

[6]  J. Guarro,et al.  Molecular Phylogeny and Proposal of Two New Species of the Emerging Pathogenic Fungus Saksenaea , 2010, Journal of Clinical Microbiology.

[7]  R. Arenas,et al.  Other fungi causing onychomycosis. , 2010, Clinics in dermatology.

[8]  F. Grenouillet,et al.  Molecular and Phenotypic Evaluation of Lichtheimia corymbifera (Formerly Absidia corymbifera) Complex Isolates Associated with Human Mucormycosis: Rehabilitation of L. ramosa , 2009, Journal of Clinical Microbiology.

[9]  M. J. Buitrago,et al.  In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis , 2006, Antimicrobial Agents and Chemotherapy.